标题
Targeting the Th17 pathway in psoriasis
作者
关键词
-
出版物
JOURNAL OF LEUKOCYTE BIOLOGY
Volume 92, Issue 6, Pages 1187-1197
出版商
Wiley
发表日期
2012-09-08
DOI
10.1189/jlb.0212101
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
- (2014) J. Pene et al. JOURNAL OF IMMUNOLOGY
- Identification of SR2211: A Potent Synthetic RORγ-Selective Modulator
- (2012) Naresh Kumar et al. ACS Chemical Biology
- Incyte comes of age with JAK inhibitor approval
- (2012) Nuala Moran NATURE BIOTECHNOLOGY
- Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
- (2012) Kim A. Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
- (2012) Craig Leonardi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psoriasis
- (2011) Gayathri K. Perera et al. Annual Review of Pathology-Mechanisms of Disease
- A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone
- (2011) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- Brief Report: A phase IIa, randomized, double-blind, placebo-controlled trial of apilimod mesylate, an interleukin-12/interleukin-23 inhibitor, in patients with rheumatoid arthritis
- (2011) Sarah Krausz et al. ARTHRITIS AND RHEUMATISM
- Briakinumab for the Treatment of Plaque Psoriasis
- (2011) Pawel Traczewski et al. BIODRUGS
- JAK inhibitors in myeloproliferative neoplasms: Rationale, current data and perspective
- (2011) A. Tefferi et al. BLOOD REVIEWS
- Mouse T helper 17 phenotype: Not so different than in man after all
- (2011) Francesco Annunziato et al. CYTOKINE
- Calcipotriol/Betamethasone Dipropionate
- (2011) Paul L. McCormack DRUGS
- Dynamics and non-canonical aspects of JAK/STAT signalling
- (2011) Anne Mohr et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Interleukin-17C Promotes Th17 Cell Responses and Autoimmune Disease via Interleukin-17 Receptor E
- (2011) Seon Hee Chang et al. IMMUNITY
- Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
- (2011) Yihua Cai et al. IMMUNITY
- Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein
- (2011) Tao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Involvement of Tyrosine Kinase-2 in Both the IL-12/Th1 and IL-23/Th17 Axes In Vivo
- (2011) M. Ishizaki et al. JOURNAL OF IMMUNOLOGY
- Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model
- (2011) Kimiko Nakajima et al. JOURNAL OF IMMUNOLOGY
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation
- (2011) Jordan S. Fridman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A Phase III, Randomized, Controlled Trial of the Fully Human IL-12/23 mAb Briakinumab in Moderate-to-Severe Psoriasis
- (2011) Kenneth B. Gordon et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- 1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
- (2011) S. Joshi et al. MOLECULAR AND CELLULAR BIOLOGY
- Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity
- (2011) Jun R. Huh et al. NATURE
- Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand
- (2011) Laura A. Solt et al. NATURE
- IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens
- (2011) Xinyang Song et al. NATURE IMMUNOLOGY
- Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)
- (2011) Dongxu Sun et al. NATURE IMMUNOLOGY
- IL-17C regulates the innate immune function of epithelial cells in an autocrine manner
- (2011) Vladimir Ramirez-Carrozzi et al. NATURE IMMUNOLOGY
- The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation
- (2011) Katarzyna Bulek et al. NATURE IMMUNOLOGY
- A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis
- (2011) Kristian Reich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
- (2011) A. Puel et al. SCIENCE
- T helper 17 cell heterogeneity and pathogenicity in autoimmune disease
- (2011) Kamran Ghoreschi et al. TRENDS IN IMMUNOLOGY
- 4SC-101, A Novel Small Molecule Dihydroorotate Dehydrogenase Inhibitor, Suppresses Systemic Lupus Erythematosus in MRL-(Fas)lpr Mice
- (2010) Onkar P. Kulkarni et al. AMERICAN JOURNAL OF PATHOLOGY
- LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study
- (2010) M. C. Genovese et al. ARTHRITIS AND RHEUMATISM
- Benefit-risk assessment of tumour necrosis factor antagonists in the treatment of psoriasis
- (2010) R.G. Langley et al. BRITISH JOURNAL OF DERMATOLOGY
- Ligand regulation of retinoic acid receptor-related orphan receptors: implications for development of novel therapeutics
- (2010) Laura A Solt et al. CURRENT OPINION IN LIPIDOLOGY
- 1α,25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells
- (2010) Utako Ikeda et al. IMMUNOLOGY LETTERS
- 4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease†
- (2010) Leo R. Fitzpatrick et al. INFLAMMATORY BOWEL DISEASES
- Cutting Edge: A Critical Functional Role for IL-23 in Psoriasis
- (2010) G. Tonel et al. JOURNAL OF IMMUNOLOGY
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
- IL-23-Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A
- (2010) H. L. Rizzo et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
- (2010) A. J. Hueber et al. JOURNAL OF IMMUNOLOGY
- Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
- (2010) Debra M Meyer et al. Journal of Inflammation-London
- Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
- (2010) Christopher E.M. Griffiths et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
- (2010) Pieter C. M. Res et al. PLoS One
- Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
- (2010) W. Hueber et al. Science Translational Medicine
- Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin
- (2009) C. Johansen et al. BRITISH JOURNAL OF DERMATOLOGY
- Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
- (2009) S. Brand GUT
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic Responses
- (2009) Harumichi Ishigame et al. IMMUNITY
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohnʼs disease
- (2009) Bruce E. Sands et al. INFLAMMATORY BOWEL DISEASES
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis
- (2009) Mary G. Boy et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis
- (2009) Erin G. Harper et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis
- (2009) Shinji Kagami et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
- (2009) Consuelo Ortega et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo
- (2009) Mandy J McGeachy et al. NATURE IMMUNOLOGY
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
- (2008) Xuexian O. Yang et al. IMMUNITY
- Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt
- (2008) Kenji Ichiyama et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of inflammatory responses by IL-17F
- (2008) Xuexian O. Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations inSTAT3
- (2008) Cindy S. Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells
- (2008) Michelle A. Lowes et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis Is Characterized by Accumulation of Immunostimulatory and Th1/Th17 Cell-Polarizing Myeloid Dendritic Cells
- (2008) Lisa C. Zaba et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)
- (2008) Craig L Leonardi et al. LANCET
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)
- (2008) Kim A Papp et al. LANCET
- IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?
- (2007) Erik Lubberts CYTOKINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation